Synthesis, Crystal Structure, and Activity of Pyrazole-Based Inhibitors of p38 Kinase
Citations Over TimeTop 14% of 2007 papers
Abstract
A series of pyrazole inhibitors of p38 mitogen-activated protein (MAP) kinase were designed using a binding model based on the crystal structure of 1 (SC-102) bound to p38 enzyme. New chemistry using dithietanes was developed to assemble nitrogen-linked substituents at the 5-position of pyrazoles. Calculated log D was used in tandem with structure-based design to guide medicinal chemistry strategy and improve the in vivo activity of a series of molecules. The crystal structure of an optimized inhibitor, 4 (SC-806), in complex with p38 enzyme was obtained to confirm the hypothesis that the addition of a basic nitrogen to the molecule induces an interaction with Asp112 of p38 alpha. A compound identified from this series was efficacious in an animal model of rheumatic disease.
Related Papers
- → Design, synthesis, and evaluation of 3,4-disubstituted pyrazole analogues as anti-tumor CDK inhibitors(2007)121 cited
- → 4,5-Dihydro-1H-pyrazole Derivatives with Inhibitory nNOS Activity in Rat Brain: Synthesis and Structure−Activity Relationships(2004)67 cited
- → Non-oxime pyrazole based inhibitors of B-Raf kinase(2010)45 cited
- → Design, synthesis and molecular simulation studies of dihydrostilbene derivatives as potent tyrosinase inhibitors(2012)41 cited
- → New cytotoxic benzosuberene analogs. Synthesis, molecular modeling and biological evaluation(2013)18 cited